results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
Published 5 months ago • 172 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:05
investigating mutation order in aml using single-cell sequencing
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
1:25
preliminary results from a phase ib trial of as-1763, a novel non-covalent btki, in cll/mcl
-
55:57
defining regeneration and non-regeneration at a cellular and molecular level
-
42:37
flow cytometry basics: overcome technical challenges [webinar]
-
48:52
natural killer cells remember - lewis lanier
-
0:59
next steps for gene-edited nk cells in the treatment of hematological malignancies
-
2:41
cell avidity as a predictor of t-cell efficacy
-
2:41
an overview of the latest advances in hematology
-
1:19
gene editing of nkg2a to enhance nk cell cytotoxicity against multiple myeloma cells
-
2:34
results from a single-cell spatial analysis of the renal al amyloidosis immunome
-
0:28
label-free live cell imaging: t-cells killing cancer cells - zoomed-in
-
3:40
results of a study evaluating the predictive power of fish markers for pfs in al amyloidosis
-
0:55
a pooled analysis to determine the optimal ki-67 index cut-off point for predicting outcomes in mcl
-
1:21
the correlation between jak2v617f molecular response and efs in patients with early pv
-
0:57
using single-cell rna sequencing & proteomics to identify novel cell surface targets in aml
-
3:46
variant allele frequency in patients with sf3b1-mutated mds
-
1:57
perspectives on allogeneic nk cell-based immunotherapy
-
2:01
flow cytometry-based cytotoxicity assay to assess nk cell activity | protocol preview